Stock Events

Stock Events

Hamlet BioPharma AB (publ) 

€0.4430
0
-€0.00-0.11% 20:42 Today

Statistics

Day High
0.4435
Day Low
0.443
52W High
0.78
52W Low
0.372
Volume
-
Avg. Volume
-
Mkt Cap
64.11M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-8.65MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Hamlet BioPharma AB (publ) engages in the development of drugs for the treatment and prevention of cancer in Sweden. It is developing HAMLET, a tumoricidal protein-lipid complex formed by two generally regarded as safe (GRAS) molecules found in human milk for various oncology markets, including colon, bladder, and cervix cancers, as well as primary or metastatic brain tumors. The company's products under development include Alpha1H for the treatment of bladder cancer and brain tumors; and BAMLET for the treatment of colon and oral cancer. The company was formerly known as Hamlet Pharma AB (publ) and changed its name to Hamlet BioPharma AB (publ) in August 2023. Hamlet BioPharma AB (publ) was incorporated in 1999 and is based in Lund, Sweden. Hamlet BioPharma AB (publ) is a subsidiary of Linnane Pharma AB.
Show More
CEO
Dr. Catharina Svanborg M.D.
Employees
7
Country
Sweden
ISIN
SE0015661152
WKN
000A3CMH3

Listings

STU
DE
7ZT.STU
F
DE
7ZT.F

0 Comments

Share your thoughts

FAQs

What is Hamlet BioPharma AB (publ) stock price today?▼
The current price of 7ZT.F is €0.44 EUR — it has decreased by -0.11% in the past 24 hours. Watch Hamlet BioPharma AB (publ) stock price performance more closely on the chart.
What is Hamlet BioPharma AB (publ) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Hamlet BioPharma AB (publ) stocks are traded under the ticker 7ZT.F.
Is Hamlet BioPharma AB (publ) stock price growing?▼
7ZT.F stock has fallen by -6.34% compared to the previous week, the month change is a -12.45% fall, over the last year Hamlet BioPharma AB (publ) has showed a +2.31% increase.
What is Hamlet BioPharma AB (publ) market cap?▼
Today Hamlet BioPharma AB (publ) has the market capitalization of 64.11M
What is Hamlet BioPharma AB (publ) revenue for the last year?▼
Hamlet BioPharma AB (publ) revenue for the last year amounts to 0 EUR.
What is Hamlet BioPharma AB (publ) net income for the last year?▼
7ZT.F net income for the last year is -8.65M EUR.
How many employees does Hamlet BioPharma AB (publ) have?▼
As of November 2, 2026, the company has 7 employees.
In which sector is Hamlet BioPharma AB (publ) located?▼
Hamlet BioPharma AB (publ) operates in the Health & Wellness sector.
When did Hamlet BioPharma AB (publ) complete a stock split?▼
Hamlet BioPharma AB (publ) has not had any recent stock splits.
Where is Hamlet BioPharma AB (publ) headquartered?▼
Hamlet BioPharma AB (publ) is headquartered in Lund, Sweden.